Skip to main content
Have a personal or library account? Click to login
Eosinophil activation markers in clonal and non-clonal eosinophilia Cover

Eosinophil activation markers in clonal and non-clonal eosinophilia

Revista Romana de Medicina de Laborator
Volume 21 (2013): Issue 3 (September 2013)
By: ,  ,  ,  ,  ,   and    
Open Access
|Sep 2013
References

References

  1. 1. Rosenberg H.F.,Dyer K.D.,Foster P.S. Eosinophils: changing perspectives in health and Disease. Nat Rev Immunol. 2013 Jan;13(1):9-22.
    Open DOISearch in Google Scholar
  2. 2. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008 May;38(5):709-50.
    Open DOISearch in Google Scholar
  3. 3. Jacobsen EA,Richard A. Helmers2, Lee JJ, Lee NA. The expanding role(s) of eosinophils in health and disease. Blood. 2012 Nov 8;120(19):3882-90.
    Open DOISearch in Google Scholar
  4. 4. Horny HP, Sotlar K, Valent P. Eosinophil, basophil, and mast cell infiltrates in the bone marrow: crossing the boundaries of diagnosis. Journal of Hematopathology. 2011;4(2):101-111.
    Open DOISearch in Google Scholar
  5. 5. Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol. 2006 Jun;133(5):468-92.
    Open DOISearch in Google Scholar
  6. 6. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30;114(5):937-51.
    Open DOISearch in Google Scholar
  7. 7. Valent P. Pathogenesis, classification, and therapy of eosinophilia and eosinophilic disorders. Blood Rev. 2009 Jul;23(4):157-65.
    Open DOISearch in Google Scholar
  8. 8. Chusid MJ, Dale CD, West BC, Wolff SM .The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975 Jan;54(1):1-27.
    Open DOISearch in Google Scholar
  9. 9. Park YJ, Oh EJ, Park JW, Kim M, Han K. Plasma eosinophil cationic protein, interleukin-5, and ECP/Eo count ratio in patients with various eosinophilic diseases. Ann Clin Lab Sci. 2006;36(3):262-6.
    Search in Google Scholar
  10. 10. Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy. 1999 Sep;29(9):1172-86.
    Open DOISearch in Google Scholar
  11. 11. Davies L, Gather U. The Identification of Multiple Outliers. Journal of the American Statistical Association. 1993 Sep;88(423):782-92.
    Open DOISearch in Google Scholar
  12. 12. Rousseeuw PJ, Croux C. Alternatives to the Median Absolute Deviation. Journal of the American Statistical Association. 1993 Sep;88(424):173-83.
    Open DOISearch in Google Scholar
  13. 13. Mizera I, Muller CH. Location-Scale Depth. Journal of the American Statistical Association. 2004 Dec;99(468):949-89.
    Open DOISearch in Google Scholar
  14. 14. Gotlib J. Eosinophilic myeloid disorders: new classification and novel therapeutic strategies. Curr Opin Hematol. 2010 Mar;17(2):117-24.
    Open DOISearch in Google Scholar
  15. 15. Liso V., Troccoli G., Specchia G. and Magno M. Cytochemical “normal” and “abnormal” eosinophils in acute leukemias. Am J Hematol. 1977;2(2): 123-31.
    Open DOISearch in Google Scholar
  16. 16. Karasuyama H, Mukai K, Tsujimura Y, Obata K. Newly discovered roles for basophils: a neglected minority gains new respect. Nat Rev Immunol. 2009 Jan;9(1): 9-13.
    Open DOISearch in Google Scholar
  17. 17. Chang HW, Leong KH, Koh DR, Lee SH. Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood. 1999 Mar 1;93(5):1651-7.
    Open DOISearch in Google Scholar
  18. 18. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003 Mar 27;348(13):1201-14.
    Open DOISearch in Google Scholar
  19. 19. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007 Aug 10;25(23): 3503-10.
    Open DOISearch in Google Scholar
  20. 20. Matsushima T, Handa H, Yokohama A, Nagasaki J, Koiso H, Kin K, et al. Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia. Blood. 2003 May 1;101(9):3386-90.
    Open DOISearch in Google Scholar
  21. 21. Roufosse F, Garaud S, de Leval L. Lymphoproliferative Disorders Associated With Hypereosinophilia. Semin Hematol. 2012 Apr;49(2):138-48.
    Open DOISearch in Google Scholar
  22. 22. von Wasielewski R, Seth S, Franklin J, Fischer R, Hubner K, Hansmann ML et al. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood. 2000 Feb 15;95(4):1207-13.
    Open DOISearch in Google Scholar
  23. 23. Stanelle J, Doring C, Hansmann ML, Kuppers R. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells. Blood. 2010 Nov 18;116(20):4202-11.
    Open DOISearch in Google Scholar
  24. 24. Chu VT, Frohlich A, Steinhauser G, Scheel T, Roch T, Fillatreau S, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol. 2011 Feb; 12(2):151-9.
    Open DOISearch in Google Scholar
  25. 25. Simson L, Ellyard JI, Dent LA, Matthaei KI, Rothenberg ME, Foster PS, et al. Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol. 2007 Apr 1;178(7):4222-9.
    Open DOISearch in Google Scholar
  26. 26. Cormier S, Taranova A, Bedient C, Nguyen T, Protheroe C, Pero R et al. Pivotal advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol. 2006 Jun; 79(6):1131-9.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/rrlm-2013-0024 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Journal RSS Feed
Language: English, Romanian
Page range: 311 - 320
Published on: Sep 19, 2013
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Keywords:
Eosinophilia,
eosinophil cationic protein,
interleukin 5,
absolute eosinophil count
Related subjects:
Life sciences,
Molecular biology

© 2013 Silvana Angelescu, Cristina Mambet, Delia I. Mut Popescu, Nicoleta M. Berbec, Andra Costache, Mihai Isaroiu, Anca R. Lupu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.

Volume 21 (2013): Issue 3 (September 2013)
Previous article
Next article